 | • レポートコード：D0GIR-00279 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、子宮内膜癌の世界市場を広く調査・分析し、今後の市場展望をまとめております。子宮内膜癌の種類別市場規模（子宮摘出術、放射線療法、ホルモン療法、化学療法）、用途別市場規模（病院、クリニック、婦人科センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Lupin、GE、Johnson & Johnson、Celgene、Boston Scientific、Bayer AG、Koninklijke Philips、Karl Storz、LiNA Medical、Cooper Surgical、Hologic ・地域別グローバル市場分析 2015年-2020年 ・子宮内膜癌の北米市場（アメリカ、カナダ、メキシコ） ・子宮内膜癌のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・子宮内膜癌のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・子宮内膜癌の南米市場（ブラジル、アルゼンチン） ・子宮内膜癌の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：子宮摘出術、放射線療法、ホルモン療法、化学療法 ・用途別分析：病院、クリニック、婦人科センター、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Endometrial Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Endometrial Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Endometrial Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Endometrial Cancer market has been segmented into:
Hysterectomy Techniques
Radiation
Hormone Therapy
Chemotherapy
By Application, Endometrial Cancer has been segmented into:
Hospitals
Clinics
Gynecology Centers
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Endometrial Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Endometrial Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Endometrial Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Endometrial Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Endometrial Cancer Market Share Analysis
Endometrial Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Endometrial Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Endometrial Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Endometrial Cancer are:
Pfizer
Lupin
GE
Johnson & Johnson
Celgene
Boston Scientific
Bayer AG
Koninklijke Philips
Karl Storz
LiNA Medical
Cooper Surgical
Hologic
Table of Contents
1 Endometrial Cancer Market Overview
1.1 Product Overview and Scope of Endometrial Cancer
1.2 Classification of Endometrial Cancer by Type
1.2.1 Global Endometrial Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Endometrial Cancer Revenue Market Share by Type in 2019
1.2.3 Hysterectomy Techniques
1.2.4 Radiation
1.2.5 Hormone Therapy
1.2.6 Chemotherapy
1.3 Global Endometrial Cancer Market by Application
1.3.1 Overview: Global Endometrial Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Gynecology Centers
1.3.5 Others
1.4 Global Endometrial Cancer Market by Regions
1.4.1 Global Endometrial Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Endometrial Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Endometrial Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Endometrial Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endometrial Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Endometrial Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endometrial Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 Lupin
2.2.1 Lupin Details
2.2.2 Lupin Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Lupin SWOT Analysis
2.2.4 Lupin Product and Services
2.2.5 Lupin Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 GE
2.3.1 GE Details
2.3.2 GE Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GE SWOT Analysis
2.3.4 GE Product and Services
2.3.5 GE Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Johnson & Johnson
2.4.1 Johnson & Johnson Details
2.4.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Johnson & Johnson SWOT Analysis
2.4.4 Johnson & Johnson Product and Services
2.4.5 Johnson & Johnson Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 Celgene
2.5.1 Celgene Details
2.5.2 Celgene Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Celgene SWOT Analysis
2.5.4 Celgene Product and Services
2.5.5 Celgene Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boston Scientific
2.6.1 Boston Scientific Details
2.6.2 Boston Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Boston Scientific SWOT Analysis
2.6.4 Boston Scientific Product and Services
2.6.5 Boston Scientific Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bayer AG
2.7.1 Bayer AG Details
2.7.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bayer AG SWOT Analysis
2.7.4 Bayer AG Product and Services
2.7.5 Bayer AG Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Koninklijke Philips
2.8.1 Koninklijke Philips Details
2.8.2 Koninklijke Philips Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Koninklijke Philips SWOT Analysis
2.8.4 Koninklijke Philips Product and Services
2.8.5 Koninklijke Philips Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Karl Storz
2.9.1 Karl Storz Details
2.9.2 Karl Storz Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Karl Storz SWOT Analysis
2.9.4 Karl Storz Product and Services
2.9.5 Karl Storz Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.10 LiNA Medical
2.10.1 LiNA Medical Details
2.10.2 LiNA Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 LiNA Medical SWOT Analysis
2.10.4 LiNA Medical Product and Services
2.10.5 LiNA Medical Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cooper Surgical
2.11.1 Cooper Surgical Details
2.11.2 Cooper Surgical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Cooper Surgical SWOT Analysis
2.11.4 Cooper Surgical Product and Services
2.11.5 Cooper Surgical Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.12 Hologic
2.12.1 Hologic Details
2.12.2 Hologic Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Hologic SWOT Analysis
2.12.4 Hologic Product and Services
2.12.5 Hologic Endometrial Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Endometrial Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Endometrial Cancer Players Market Share
3.2.2 Top 10 Endometrial Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Endometrial Cancer Revenue and Market Share by Regions
4.2 North America Endometrial Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Endometrial Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Endometrial Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Endometrial Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Endometrial Cancer Revenue and Growth Rate (2015-2020)
5 North America Endometrial Cancer Revenue by Countries
5.1 North America Endometrial Cancer Revenue by Countries (2015-2020)
5.2 USA Endometrial Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Endometrial Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Endometrial Cancer Revenue and Growth Rate (2015-2020)
6 Europe Endometrial Cancer Revenue by Countries
6.1 Europe Endometrial Cancer Revenue by Countries (2015-2020)
6.2 Germany Endometrial Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Endometrial Cancer Revenue and Growth Rate (2015-2020)
6.4 France Endometrial Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Endometrial Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Endometrial Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Endometrial Cancer Revenue by Countries
7.1 Asia-Pacific Endometrial Cancer Revenue by Countries (2015-2020)
7.2 China Endometrial Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Endometrial Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Endometrial Cancer Revenue and Growth Rate (2015-2020)
7.5 India Endometrial Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Endometrial Cancer Revenue and Growth Rate (2015-2020)
8 South America Endometrial Cancer Revenue by Countries
8.1 South America Endometrial Cancer Revenue by Countries (2015-2020)
8.2 Brazil Endometrial Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Endometrial Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Endometrial Cancer by Countries
9.1 Middle East & Africa Endometrial Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Endometrial Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Endometrial Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Endometrial Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Endometrial Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Endometrial Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Endometrial Cancer Market Forecast by Type (2019-2024)
10.3 Hysterectomy Techniques Revenue Growth Rate (2015-2025)
10.4 Radiation Revenue Growth Rate (2015-2025)
10.5 Hormone Therapy Revenue Growth Rate (2015-2025)
10.6 Chemotherapy Revenue Growth Rate (2015-2025)
11 Global Endometrial Cancer Market Segment by Application
11.1 Global Endometrial Cancer Revenue Market Share by Application (2015-2020)
11.2 Endometrial Cancer Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Gynecology Centers Revenue Growth (2015-2020)
11.6 Others Revenue Growth (2015-2020)
12 Global Endometrial Cancer Market Size Forecast (2021-2025)
12.1 Global Endometrial Cancer Market Size Forecast (2021-2025)
12.2 Global Endometrial Cancer Market Forecast by Regions (2021-2025)
12.3 North America Endometrial Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Endometrial Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Endometrial Cancer Revenue Market Forecast (2021-2025)
12.6 South America Endometrial Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Endometrial Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Endometrial Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Endometrial Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Endometrial Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Endometrial Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Endometrial Cancer Major Business
Table 7. Pfizer Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Endometrial Cancer Product and Solutions
Table 10. Pfizer Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Lupin Corporate Information, Location and Competitors
Table 12. Lupin Endometrial Cancer Major Business
Table 13. Lupin Endometrial Cancer Total Revenue (USD Million) (2018-2019)
Table 14. Lupin SWOT Analysis
Table 15. Lupin Endometrial Cancer Product and Solutions
Table 16. Lupin Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GE Corporate Information, Location and Competitors
Table 18. GE Endometrial Cancer Major Business
Table 19. GE Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 20. GE SWOT Analysis
Table 21. GE Endometrial Cancer Product and Solutions
Table 22. GE Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Johnson & Johnson Corporate Information, Location and Competitors
Table 24. Johnson & Johnson Endometrial Cancer Major Business
Table 25. Johnson & Johnson Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Johnson & Johnson SWOT Analysis
Table 27. Johnson & Johnson Endometrial Cancer Product and Solutions
Table 28. Johnson & Johnson Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Celgene Corporate Information, Location and Competitors
Table 30. Celgene Endometrial Cancer Major Business
Table 31. Celgene Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 32. Celgene SWOT Analysis
Table 33. Celgene Endometrial Cancer Product and Solutions
Table 34. Celgene Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Boston Scientific Corporate Information, Location and Competitors
Table 36. Boston Scientific Endometrial Cancer Major Business
Table 37. Boston Scientific Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Boston Scientific SWOT Analysis
Table 39. Boston Scientific Endometrial Cancer Product and Solutions
Table 40. Boston Scientific Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bayer AG Corporate Information, Location and Competitors
Table 42. Bayer AG Endometrial Cancer Major Business
Table 43. Bayer AG Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Bayer AG SWOT Analysis
Table 45. Bayer AG Endometrial Cancer Product and Solutions
Table 46. Bayer AG Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Koninklijke Philips Corporate Information, Location and Competitors
Table 48. Koninklijke Philips Endometrial Cancer Major Business
Table 49. Koninklijke Philips Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Koninklijke Philips SWOT Analysis
Table 51. Koninklijke Philips Endometrial Cancer Product and Solutions
Table 52. Koninklijke Philips Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Karl Storz Corporate Information, Location and Competitors
Table 54. Karl Storz Endometrial Cancer Major Business
Table 55. Karl Storz Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Karl Storz SWOT Analysis
Table 57. Karl Storz Endometrial Cancer Product and Solutions
Table 58. Karl Storz Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. LiNA Medical Corporate Information, Location and Competitors
Table 60. LiNA Medical Endometrial Cancer Major Business
Table 61. LiNA Medical Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 62. LiNA Medical SWOT Analysis
Table 63. LiNA Medical Endometrial Cancer Product and Solutions
Table 64. LiNA Medical Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Cooper Surgical Corporate Information, Location and Competitors
Table 66. Cooper Surgical Endometrial Cancer Major Business
Table 67. Cooper Surgical Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 68. Cooper Surgical SWOT Analysis
Table 69. Cooper Surgical Endometrial Cancer Product and Solutions
Table 70. Cooper Surgical Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Hologic Corporate Information, Location and Competitors
Table 72. Hologic Endometrial Cancer Major Business
Table 73. Hologic Endometrial Cancer Total Revenue (USD Million) (2017-2018)
Table 74. Hologic SWOT Analysis
Table 75. Hologic Endometrial Cancer Product and Solutions
Table 76. Hologic Endometrial Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Global Endometrial Cancer Revenue (Million USD) by Players (2015-2020)
Table 78. Global Endometrial Cancer Revenue Share by Players (2015-2020)
Table 79. Global Endometrial Cancer Revenue (Million USD) by Regions (2015-2020)
Table 80. Global Endometrial Cancer Revenue Market Share by Regions (2015-2020)
Table 81. North America Endometrial Cancer Revenue by Countries (2015-2020)
Table 82. North America Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Table 83. Europe Endometrial Cancer Revenue (Million USD) by Countries (2015-2020)
Table 84. Asia-Pacific Endometrial Cancer Revenue (Million USD) by Countries (2015-2020)
Table 85. South America Endometrial Cancer Revenue by Countries (2015-2020)
Table 86. South America Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Table 87. Middle East and Africa Endometrial Cancer Revenue (Million USD) by Countries (2015-2020)
Table 88. Middle East and Africa Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Table 89. Global Endometrial Cancer Revenue (Million USD) by Type (2015-2020)
Table 90. Global Endometrial Cancer Revenue Share by Type (2015-2020)
Table 91. Global Endometrial Cancer Revenue Forecast by Type (2021-2025)
Table 92. Global Endometrial Cancer Revenue by Application (2015-2020)
Table 93. Global Endometrial Cancer Revenue Share by Application (2015-2020)
Table 94. Global Endometrial Cancer Revenue Forecast by Application (2021-2025)
Table 95. Global Endometrial Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Endometrial Cancer Picture
Figure 2. Global Endometrial Cancer Revenue Market Share by Type in 2019
Figure 3. Hysterectomy Techniques Picture
Figure 4. Radiation Picture
Figure 5. Hormone Therapy Picture
Figure 6. Chemotherapy Picture
Figure 7. Endometrial Cancer Revenue Market Share by Application in 2019
Figure 8. Hospitals Picture
Figure 9. Clinics Picture
Figure 10. Gynecology Centers Picture
Figure 11. Others Picture
Figure 12. Global Endometrial Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Endometrial Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Endometrial Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Endometrial Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Endometrial Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Endometrial Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Endometrial Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Endometrial Cancer Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Endometrial Cancer Revenue Market Share in 2019
Figure 21. Global Top 10 Players Endometrial Cancer Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Endometrial Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Endometrial Cancer Revenue Market Share by Regions (2015-2020)
Figure 25. Global Endometrial Cancer Revenue Market Share by Regions in 2018
Figure 26. North America Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 27. Europe Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 29. South America Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 31. North America Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Figure 32. North America Endometrial Cancer Revenue Market Share by Countries in 2019
Figure 33. USA Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Canada Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 36. Europe Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Endometrial Cancer Revenue Market Share by Countries in 2019
Figure 38. Germany Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 39. UK Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 40. France Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Russia Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 42. Italy Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Endometrial Cancer Revenue Market Share by Countries in 2019
Figure 45. China Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 46. Japan Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 47. Korea Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 48. India Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 50. South America Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Figure 51. South America Endometrial Cancer Revenue Market Share by Countries in 2019
Figure 52. Brazil Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Endometrial Cancer Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Endometrial Cancer Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 57. UAE Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Endometrial Cancer Revenue and Growth Rate (2015-2020)
Figure 60. Global Endometrial Cancer Revenue Share by Type (2015-2020)
Figure 61. Global Endometrial Cancer Revenue Share by Type in 2019
Figure 62. Global Endometrial Cancer Market Share Forecast by Type (2021-2025)
Figure 63. Global Hysterectomy Techniques Revenue Growth Rate (2015-2020)
Figure 64. Global Radiation Revenue Growth Rate (2015-2020)
Figure 65. Global Hormone Therapy Revenue Growth Rate (2015-2020)
Figure 66. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 67. Global Endometrial Cancer Revenue Share by Application (2015-2020)
Figure 68. Global Endometrial Cancer Revenue Share by Application in 2019
Figure 69. Global Endometrial Cancer Market Share Forecast by Application (2021-2025)
Figure 70. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 71. Global Clinics Revenue Growth Rate (2015-2020)
Figure 72. Global Gynecology Centers Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Endometrial Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Endometrial Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Endometrial Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Endometrial Cancer Revenue Market Forecast (2021-2025)
Figure 78. Europe Endometrial Cancer Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Endometrial Cancer Revenue Market Forecast (2021-2025)
Figure 80. South America Endometrial Cancer Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Endometrial Cancer Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
子宮内膜アブレーションの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Endometrial Ablation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.8% in the forecast period of 2020 to 2025 and will expected to reach USD 75 million by 2025, from USD 67 million in 2019. The Endometrial Ablation ma…- がん治療・バイオ治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cancer Therapeutics And Biotherapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.2% in the forecast period of 2020 to 2025 and will expected to reach USD 10550 million by 2025, from USD 8959.4 million in 2019. T…
- 上咽頭がんの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Nasopharyngeal Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Nasopharyngeal Cancer m…
- 非血液がん治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Non-Hematological Cancer Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Non-Hemato…
- がん輸液療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cancer Infusion Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…